https://www.selleckchem.com/products/aunp-12.html
Oxaliplatin (OXP), a 3rd generation platinum compound, which causes severe side effects due to; impulse high concentration in the bloodstream thereby exposing healthy cells at a high ratio, nonspecific delivery at the target site and non-compliance is administered intravenously. The project was aimed at the development, characterization, and in-vitro and in-vivo evaluation of pHresponsive hydrogels for oral administration of OXP. Hydrogel formulations were synthesized through a free radical polymerization technique followed by brief cha
Like
Comment
Share
